CoChat

Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence.

Open access
Morancho, Beatriz, Martínez-Barriocanal, Águeda, Villanueva, Josep, Arribas, Joaquín · 2015 · Breast Cancer Research

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Cellular senescence is a terminal cell proliferation arrest that can be triggered by oncogenes. One of the traits of oncogene-induced senescence (OIS) is the so-called senescence-associated secretory phenotype or senescence secretome. Depending on the context, the non-cell autonomous effects of OIS may vary from tumor suppression to promotion of metastasis. Despite being such a physiological and pathologically relevant effector, the mechanisms of generation of the senescence secretome are largely unknown. METHODS: We analyzed by label-free proteomics the secretome of p95HER2-induced senescent cells and compared the levels of the membrane-anchored proteins with their transcript levels. Then, protein and RNA levels of ADAM17 were evaluated by using Western blot and reverse transcription-polymerase chain reaction, its localization by using biotin labeling and immunofluorescence, and its activity by using alkaline phosphatase-tagged substrates. The p95HER2-expressing cell lines, senescent MCF7 and proliferating MCF10A, were analyzed to study ADAM17 regulation. Finally, we knocked down ADAM17 to determine its contribution to the senescence-associated secretome. The effect of this secretome was evaluated in migration assays in vitro and in nude mice by assessing the metastatic ability of orthotopically co-injected non-senescent cells. RESULTS: Using breast cancer cells expressing p95HER2, a constitutively active fragment of the proto-oncogene HER2 that induces OIS, we show that the extracellular domains of a variety of membrane-bound proteins form part of the senescence secretome. We determine that these proteins are regulated transcriptionally and, in addition, that their shedding is limited by the protease ADAM17. The activity of the sheddase is constrained, at least in part, by the accumulation of cellular cholesterol. The blockade of ADAM17 abrogates several prometastatic effects of the p95HER2-induced senescence secretome, both in vitro and in vivo. CONCLUSIONS: Considering these findings, we conclude that ectodomain shedding is tightly regulated in oncogene-induced senescent cells by integrating transcription of the shedding substrates with limiting ADAM17 activity. The remaining activity of ADAM17 contributes to the non-cell autonomous protumorigenic effects of p95HER2-induced senescent cells. Because ADAM17 is druggable, these results represent an approximation to the pharmacological regulation of the senescence secretome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13058-015-0619-7

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Protein ectodomain shedding during p95HER2-induced senescence. a Left, MCF7 Tet-Off p95HER2 cells were treated with or without doxycycline as indicated in two independent experiments (#1 and #2). The extracellular media were analyzed by label-free quantitative proteomics in triplicate (A-C) (Additional file 1: Figure. S1). The heatmap shows log2FC of the normalized levels of soluble ectodomains. Right, transcriptomic analysis of the same cells treated as in left panel (a). b MCF7 Tet-Off p95HER2 cells were treated with or without doxycycline for 7 days. Conditioned media from the last two days and cell lysates were analyzed by Western blotting as indicated. c Quantitative results from at least three independent experiments performed as in (b) were expressed as average ± standard deviation. Note that the levels of Areg were determined by enzyme-linked immunosorbent assay. d log2FC of the ectodomain levels and the log2FC of their corresponding transcripts levels, determined as described in (a), are represented. Linear regression line is shown (R2 = 0.528); P <0.001 using the Spearman correlation coefficient. APP amyloid precursor protein, Areg amphiregulin, EpCAM epithelial cell adhesion molecule, Ephrin type-B receptor 4, DDR1 discoidin domain receptor family, member 1, GAPDH glyceraldehyde 3-phosphate dehydrogenase
Fig. 1 Protein ectodomain shedding during p95HER2-induced senescence. a Left, MCF7 Tet-Off p95HER2 cells were treated with or without doxycycline as indicated in two independent experiments (#1 and #2). The extracellular media were analyzed by label-free quantitative proteomics in triplicate (A-C) (Additional file 1: Figure. S1). The heatmap shows log2FC of the normalized levels of soluble ectodomains. Right, transcriptomic analysis of the same cells treated as in left panel (a). b MCF7 Tet-Off p95HER2 cells were treated with or without doxycycline for 7 days. Conditioned media from the last two days and cell lysates were analyzed by Western blotting as indicated. c Quantitative results from at least three independent experiments performed as in (b) were expressed as average ± standard deviation. Note that the levels of Areg were determined by enzyme-linked immunosorbent assay. d log2FC of the ectodomain levels and the log2FC of their corresponding transcripts levels, determined as described in (a), are represented. Linear regression line is shown (R2 = 0.528); P <0.001 using the Spearman correlation coefficient. APP amyloid precursor protein, Areg amphiregulin, EpCAM epithelial cell adhesion molecule, Ephrin type-B receptor 4, DDR1 discoidin domain receptor family, member 1, GAPDH glyceraldehyde 3-phosphate dehydrogenaseCC BY · PubMed Central
Fig. 2 ADAM17 levels during oncogene-induced senescence. a MCF7 Tet-Off p95HER2 cells were cultured in the presence or absence of doxycycline and harvested at the specified time points. Then cells were lysed and cell lysates were analyzed by Western blotting with the indicated antibodies. The densitometric quantification of the pro- and mature forms of ADAM17 and ADAM10 was performed in four independent experiments and is expressed as average ± standard deviation. *P <0.05, **P <0.01 using the Student’s t test. b Relative ADAM17 and ADAM10 mRNA expression was determined by reverse transcription-polymerase chain reaction in the same cells as in (a). Data were normalized to 18S mRNA. Averages and standard deviations of three independent experiments are represented. Differences are not significant statistically (ns). c MCF7 Tet-Off p95HER2 cells were cultured in the presence or absence of doxycycline for 7 days and incubated with phosphate-buffered saline (unlabeled) or sulfo-NHS-LC-biotin (biotinylated) as described in the Methods section. Then cells were lysed and cell lysates were incubated with anti-ADAM17 antibody and immunoprecipitates were analyzed by Western blotting by using streptavidin-peroxidase (Str.) or anti-ADAM17 (αA17). The densitometric quantification of six independent experiments is expressed as average ± standard deviation. **P <0.01 using the Student’s t test. d Representative immunofluorescence of ADAM17 (green) and DAPI (4’,6’-diamidino-2-phenylindole) counterstaining (nuclei, red) in MCF7 Tet-Off p95HER2 cells cultured with or without doxycycline. Bottom and left panels in each image represent Z-stack integration in the X and Y dimensions, respectively. e MCF10A Tet-On p95HER2 cells were cultured for 7 days without or with doxycycline. Then senescence-associated β-galactosidase was performed. Representative bright-field images are shown. f The same cells as in (e) were lysed and cell lysates were analyzed by Western blot with the indicated antibodies. Doxy doxycycline
Fig. 2 ADAM17 levels during oncogene-induced senescence. a MCF7 Tet-Off p95HER2 cells were cultured in the presence or absence of doxycycline and harvested at the specified time points. Then cells were lysed and cell lysates were analyzed by Western blotting with the indicated antibodies. The densitometric quantification of the pro- and mature forms of ADAM17 and ADAM10 was performed in four independent experiments and is expressed as average ± standard deviation. *P <0.05, **P <0.01 using the Student’s t test. b Relative ADAM17 and ADAM10 mRNA expression was determined by reverse transcription-polymerase chain reaction in the same cells as in (a). Data were normalized to 18S mRNA. Averages and standard deviations of three independent experiments are represented. Differences are not significant statistically (ns). c MCF7 Tet-Off p95HER2 cells were cultured in the presence or absence of doxycycline for 7 days and incubated with phosphate-buffered saline (unlabeled) or sulfo-NHS-LC-biotin (biotinylated) as described in the Methods section. Then cells were lysed and cell lysates were incubated with anti-ADAM17 antibody and immunoprecipitates were analyzed by Western blotting by using streptavidin-peroxidase (Str.) or anti-ADAM17 (αA17). The densitometric quantification of six independent experiments is expressed as average ± standard deviation. **P <0.01 using the Student’s t test. d Representative immunofluorescence of ADAM17 (green) and DAPI (4’,6’-diamidino-2-phenylindole) counterstaining (nuclei, red) in MCF7 Tet-Off p95HER2 cells cultured with or without doxycycline. Bottom and left panels in each image represent Z-stack integration in the X and Y dimensions, respectively. e MCF10A Tet-On p95HER2 cells were cultured for 7 days without or with doxycycline. Then senescence-associated β-galactosidase was performed. Representative bright-field images are shown. f The same cells as in (e) were lysed and cell lysates were analyzed by Western blot with the indicated antibodies. Doxy doxycyclineCC BY · PubMed Central
Fig. 3 Contribution of ADAM17 to the p95HER2-induced senescence secretome. a MCF7 Tet-Off p95HER2 cells constitutively expressing a control shRNA (NT, non-targeting) or two independent shRNAs targeting ADAM17 (A17#1 and A17#2) were cultured with or without doxycycline for 7 days. Cells were then harvested and lysed, and cell lysates were analyzed by Western blotting with the indicated antibodies. b Senescence-associated β-galactosidase was analyzed in the same cells as in (a). Representative bright-field images are shown. c The same cells as in (a) were plated with or without doxycycline and counted at the indicated time points. The results represent averages of two independent determinations. d The conditioned media of the same cells as in (a), treated without doxycycline, were analyzed by label-free quantitative proteomics in triplicate (a-c). The heatmap shows log2FC of the normalized levels of soluble ectodomains. e-g The same cells as in (a) were treated with or without doxycycline for 7 days. Conditioned media from the last two days and cell lysates were analyzed by enzyme-linked immunosorbent assay (e) or Western blotting (f, g) as indicated. Quantification of at least three independent experiments is represented as average and standard deviation. These results were reproduced by using the second stable cell line expressing an independent shRNA targeting ADAM17 (data not shown). Doxy doxycycline
Fig. 3 Contribution of ADAM17 to the p95HER2-induced senescence secretome. a MCF7 Tet-Off p95HER2 cells constitutively expressing a control shRNA (NT, non-targeting) or two independent shRNAs targeting ADAM17 (A17#1 and A17#2) were cultured with or without doxycycline for 7 days. Cells were then harvested and lysed, and cell lysates were analyzed by Western blotting with the indicated antibodies. b Senescence-associated β-galactosidase was analyzed in the same cells as in (a). Representative bright-field images are shown. c The same cells as in (a) were plated with or without doxycycline and counted at the indicated time points. The results represent averages of two independent determinations. d The conditioned media of the same cells as in (a), treated without doxycycline, were analyzed by label-free quantitative proteomics in triplicate (a-c). The heatmap shows log2FC of the normalized levels of soluble ectodomains. e-g The same cells as in (a) were treated with or without doxycycline for 7 days. Conditioned media from the last two days and cell lysates were analyzed by enzyme-linked immunosorbent assay (e) or Western blotting (f, g) as indicated. Quantification of at least three independent experiments is represented as average and standard deviation. These results were reproduced by using the second stable cell line expressing an independent shRNA targeting ADAM17 (data not shown). Doxy doxycyclineCC BY · PubMed Central
Fig. 4 Effect of cholesterol depletion on the protein levels and activity of ADAM17 in p95HER2-induced senescent cells. a MCF7 Tet-Off p95HER2 cells were cultured with or without doxycycline for 5 days and further incubated in serum-free media with or without 1 mM MβCD for 2 additional days. Then cells were stained with filipin. Representative bright-field and filipin staining images are shown. b The same cells as in (a) were treated with different concentrations of MβCD. Control and treated cells were harvested and lysed, and cell lysates were analyzed by Western blot with the indicated antibodies. The densitometric quantification of three independent experiments is expressed as average ± standard deviation. *P <0.05 using the two-sided Student’s t test. c MCF7 Tet-Off p95HER2 or MCF10A Tet-On p95HER2 cells expressing AP-tagged TGF-α (left panels), Areg (middle panels), or BTC (right panel) were treated with or without doxycycline and MβCD or vehicle for 48 h as indicated. AP was quantified in serum-free conditioned media and cell lysates. Data shown represent the averages and standard deviations of three independent experiments. *P < 0.05 using the two-sided Student’s t test. AP alkaline phosphatase, BTC betacellulin, Doxy doxycycline, MβCD methyl-beta-cyclodextrin, TGF transforming growth factor
Fig. 4 Effect of cholesterol depletion on the protein levels and activity of ADAM17 in p95HER2-induced senescent cells. a MCF7 Tet-Off p95HER2 cells were cultured with or without doxycycline for 5 days and further incubated in serum-free media with or without 1 mM MβCD for 2 additional days. Then cells were stained with filipin. Representative bright-field and filipin staining images are shown. b The same cells as in (a) were treated with different concentrations of MβCD. Control and treated cells were harvested and lysed, and cell lysates were analyzed by Western blot with the indicated antibodies. The densitometric quantification of three independent experiments is expressed as average ± standard deviation. *P <0.05 using the two-sided Student’s t test. c MCF7 Tet-Off p95HER2 or MCF10A Tet-On p95HER2 cells expressing AP-tagged TGF-α (left panels), Areg (middle panels), or BTC (right panel) were treated with or without doxycycline and MβCD or vehicle for 48 h as indicated. AP was quantified in serum-free conditioned media and cell lysates. Data shown represent the averages and standard deviations of three independent experiments. *P < 0.05 using the two-sided Student’s t test. AP alkaline phosphatase, BTC betacellulin, Doxy doxycycline, MβCD methyl-beta-cyclodextrin, TGF transforming growth factorCC BY · PubMed Central
Fig. 5 Effect of ADAM17 knockdown on different non-cell autonomous effects of p95HER2-induced senescent cells. a Conditioned media from MCF7 Tet-Off p95HER2 shNT or shADAM17 cells cultured in serum-free media for 48 h, after 5 days of plating with or without doxycycline (see schematic drawing), were placed in the lower chamber of transwell plates; parental MCF7 or MDA-MB-231 cells were seeded on the upper chamber (schematic drawing, upper panel). After 48 or 24 h, cells in the lower compartment were stained and fixed. Representative images with MDA-MB-231 cells are shown (middle panels). Migrating cells were estimated in three independent experiments (lower panels). Bars represent averages and standard deviations. *P < 0.05, **P < 0.01, and ***P < 0.001 using the two-sided Student’s t test. b MCF7 Tet-Off p95HER2 cells constitutively expressing a control shRNA (NT, non-targeting) or a shRNA targeting ADAM17 were co-injected orthothopically with reporter MDA-MB-231 cells expressing the luciferase gene. c Tumor volumes were determined at the indicated time points and expressed as average ± standard deviation. Doxycycline was withdrawn at the time indicated as 0. d Tumor growth determined by in vivo bioluminescence at day 16 (total photon flux emission). Results are expressed as averages and standard deviations. e Representative in vivo bioluminescence images of metastatic sites 20 days after tumor resection. f Kaplan-Meier plot showing metastasis-free survival of the same mice as in (c) and (d) after tumor resection.
Fig. 5 Effect of ADAM17 knockdown on different non-cell autonomous effects of p95HER2-induced senescent cells. a Conditioned media from MCF7 Tet-Off p95HER2 shNT or shADAM17 cells cultured in serum-free media for 48 h, after 5 days of plating with or without doxycycline (see schematic drawing), were placed in the lower chamber of transwell plates; parental MCF7 or MDA-MB-231 cells were seeded on the upper chamber (schematic drawing, upper panel). After 48 or 24 h, cells in the lower compartment were stained and fixed. Representative images with MDA-MB-231 cells are shown (middle panels). Migrating cells were estimated in three independent experiments (lower panels). Bars represent averages and standard deviations. *P < 0.05, **P < 0.01, and ***P < 0.001 using the two-sided Student’s t test. b MCF7 Tet-Off p95HER2 cells constitutively expressing a control shRNA (NT, non-targeting) or a shRNA targeting ADAM17 were co-injected orthothopically with reporter MDA-MB-231 cells expressing the luciferase gene. c Tumor volumes were determined at the indicated time points and expressed as average ± standard deviation. Doxycycline was withdrawn at the time indicated as 0. d Tumor growth determined by in vivo bioluminescence at day 16 (total photon flux emission). Results are expressed as averages and standard deviations. e Representative in vivo bioluminescence images of metastatic sites 20 days after tumor resection. f Kaplan-Meier plot showing metastasis-free survival of the same mice as in (c) and (d) after tumor resection.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 13

Metadata

Authors
Morancho, B., Martínez-Barriocanal, Á., Villanueva, J., & Arribas, J.
Affiliations
Vall d'Hebron Institute of Oncology (ES)
Venue
Breast Cancer Research
Published
2015-08-12
Volume
17
Issue
1
Pages
106-106
ISSN
  • 1465-5411 (ISSN-L)
  • 1465-542X
OpenAlex
W1961478359
Cited by
13
References
37
Citations by year
2025: 1 · 2024: 2 · 2021: 4 · 2020: 2 · 2018: 2 · 2017: 1 · 2016: 1
FWCI
0.98
Type
journal article
Language
en
Open access
Locations
  • Breast Cancer Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
Funders
  • Breast Cancer Research Foundation (BCRF) (ᅟ)
  • Spanish Association Against Cancer (Asociación Española Contra el Cáncer, AECC) (ᅟ)
  • Sandra Ibarra Foundation (ᅟ)
  • Instituto de Salud Carlos III (Intrasalud PI12/02536)
  • Network of Cooperative Cancer Research (RTICC-RD12/0036)
  • Ministerio de Economía y Competitividad (JCI-2011-10960)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
ADAM17, oncogene-induced senescence, senescence-associated secretome, non-cell-autonomous effects, HER2, p95HER2, ectodomain shedding, membrane proteins, cholesterol, metastasis, tumor suppression, breast cancer, protease regulation, secretome proteomics, MCF10A, MCF-7 cells
MeSH terms
ADAM17 Protein, Proto-Oncogene Mas, Biological Transport, Cell Membrane, Enzyme Activation, Female, Humans, Oncogenes, Gene Expression, Cellular Senescence, Proteome, Gene Expression Profiling, Proteomics, Cell Line, Tumor, ADAM Proteins, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. https://app.cochat.ai/papers/10.1186/s13058-015-0619-7
The paper
Morancho, B., Martínez-Barriocanal, Á., Villanueva, J., & Arribas, J. (2015). Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Research. https://doi.org/10.1186/s13058-015-0619-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.